SPYW:F:F-SPDR S&P Euro Dividend Aristocrats UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 26.08

Change

-0.09 (-0.32)%

Market Cap

N/A

Volume

6.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict
Created with Highstock 5.0.6

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
SPYW:F
Relative Returns (From:    To: 2025-04-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 101.74B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+1.11 (+2.43%)

USD 101.37B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.95 (+1.90%)

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.29 (+2.15%)

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

-0.09 (-1.23%)

USD 53.72B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+5.65 (+2.74%)

USD 45.80B
0ZC:F Zscaler Inc

+0.02 (+0.01%)

USD 37.92B
BSND:F Danone SA

N/A

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

+0.68 (+0.59%)

USD 24.77B

ETFs Containing SPYW:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.51% 89% A- 80% B-
Dividend Return -20.73% 6% D- N/A F
Total Return -11.22% 16% F 35% F
Trailing 12 Months  
Capital Gain 11.14% 83% B 71% C-
Dividend Return -17.82% 3% F N/A F
Total Return -6.68% 17% F 39% F
Trailing 5 Years  
Capital Gain 51.49% 46% F 52% F
Dividend Return -7.81% 50% F N/A F
Total Return 43.67% 42% F 34% F
Average Annual (5 Year Horizon)  
Capital Gain 5.64% 53% F 55% F
Dividend Return 7.91% 57% F 52% F
Total Return 2.27% 54% F 55% F
Risk Return Profile  
Volatility (Standard Deviation) 10.86% 63% D 89% A-
Risk Adjusted Return 72.86% 72% C 79% B-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike